Hematin crystallization (Hz (hemozoin); β-hematin (synthetic analog))

Hematin crystallization is the primary mechanism by which Plasmodium parasites detoxify toxic heme released during the digestion of host hemoglobin. The parasite sequesters heme as inert, crystalline hemozoin (malaria pigment) within its digestive vacuole, a process essential for parasite survival. This target has been the most successful molecular focus for antimalarial drug development, with quinoline-class drugs (chloroquine, mefloquine, amodiaquine) and artemisinin-based drugs all inhibiting this crystallization process through distinct mechanisms.[1][2][3] Quinoline drugs bind to specific sites on hematin crystal surfaces and block layer growth through a step-pinning mechanism, while artemisinin drugs alkylate heme to prevent crystallization entirely.[1][2][6] Drug inhibition of hemozoin formation leads to accumulation of free, toxic heme in the parasite cytoplasm, ultimately causing parasite death.[5] However, Plasmodium falciparum has developed resistance by reducing intracellular drug concentrations, allowing effective heme detoxification despite drug presence, highlighting the importance of understanding the molecular details of this crystallization process for rational drug design.[1][2]

Other names

Heme detoxificationHemozoin formationβ-hematin crystallizationMalaria pigment crystallizationHematin crystal growth

Crystal growth inhibition: Quinoline antimalarials (chloroquine, mefloquine, amodiaquine) bind to specific crystal surface sites and block layer growth through a step-pinning mechanism. Step-pinning mechanism: Drug molecules adsorb on crystal terraces and suppress both 2D layer nucleation and step growth. Hematin complexation: Some drugs form non-crystallizable complexes with free hematin in solution, though crystal surface binding appears more efficient. Heme redistribution: Chloroquine causes redistribution of heme from the digestive vacuole to the cytoplasm, disrupting crystal growth and creating mosaic boundaries. Heme alkylation: Artemisinin-based drugs covalently modify heme, preventing its crystallization into hemozoin.